Valeo Financial Advisors, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
Valeo Financial Advisors, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$44,000
+37.5%
389
+1.6%
0.00%
+33.3%
Q1 2020$32,000
-20.0%
3830.0%0.00%
-25.0%
Q4 2019$40,0000.0%383
-4.2%
0.00%0.0%
Q3 2019$40,000
-13.0%
4000.0%0.00%
-20.0%
Q2 2019$46,000
+1433.3%
400
+1639.1%
0.01%
Q4 2018$3,000
-50.0%
23
-30.3%
0.00%
-100.0%
Q3 2018$6,000
-25.0%
33
-2.9%
0.00%0.0%
Q2 2018$8,000
+33.3%
340.0%0.00%0.0%
Q1 2018$6,000
+20.0%
34
-5.6%
0.00%0.0%
Q4 2017$5,000360.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders